|
Q |
Anxrr39 |
Anxiety related response QTL 39 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
|
|
Q |
Anxrr40 |
Anxiety related response QTL 40 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
NCBI chr 4:62,753,847...107,753,847
|
|
Q |
Anxrr42 |
Anxiety related response QTL 42 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
NCBI chr 4:144,639,524...182,687,754
|
|
Q |
Anxrr47 |
Anxiety related response QTL 47 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
NCBI chr 4:10,084,089...55,084,089
|
|
Q |
Anxrr49 |
Anxiety related response QTL 49 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
NCBI chr 4:62,753,847...107,753,847
|
|
Q |
Anxrr50 |
Anxiety related response QTL 50 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
|
|
Q |
Anxrr51 |
Anxiety related response QTL 51 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
NCBI chr 4:124,778,595...169,778,595
|
|
Q |
Emca1 |
Estrogen-induced mammary cancer QTL 1 |
|
IDA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:99,216,724...148,607,142
|
|
Q |
Emca10 |
Estrogen-induced mammary cancer QTL 10 |
|
IDA |
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 6:16,536,140...61,536,140
|
|
Q |
Emca11 |
Estrogen-induced mammary cancer QTL 11 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:99,753,548...113,061,097
|
|
Q |
Emca12 |
Estrogen-induced mammary cancer QTL 12 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:124,160,767...133,749,643
|
|
Q |
Emca13 |
Estrogen-induced mammary cancer QTL 13 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:9,823,266...99,753,708
|
|
Q |
Emca2 |
Estrogen-induced mammary cancer QTL 2 |
|
IDA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:18,007,599...63,571,040
|
|
Q |
Emca4 |
Estrogen-induced mammary cancer QTL 4 |
|
IDA |
27.5mg crystalline implant |
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:62,004,452...101,773,158
|
|
Q |
Emca5 |
Estrogen-induced mammary cancer QTL 5 |
|
IDA |
27.5mg crystalline implant |
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:43,827,364...169,034,231
|
|
Q |
Emca6 |
Estrogen-induced mammary cancer QTL 6 |
|
IDA |
27.5mg/ml crystalline implant |
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:44,463,720...155,883,716
|
|
Q |
Emca7 |
Estrogen-induced mammary cancer QTL 7 |
|
IDA |
27.5mg/ml crystalline implant |
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:15,107,216...107,351,382
|
|
Q |
Emca8 |
Estrogen-induced mammary cancer QTL 8 |
|
IDA |
27.5mg/ml crystalline implant |
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:50,328,551...141,643,988
|
|
Q |
Ept15 |
Estrogen-induced pituitary tumorigenesis QTL 15 |
|
IDA |
|
RGD |
PMID:2292503 |
RGD:7175546 |
NCBI chr 6:9,843,312...20,338,915
|
|
Q |
Ept16 |
Estrogen-induced pituitary tumorigenesis QTL 16 |
|
IDA |
|
RGD |
PMID:2292503 |
RGD:7175546 |
NCBI chr 3:47,233,430...110,362,260
|
|
Q |
Ept17 |
Estrogen-induced pituitary tumorigenesis QTL 17 |
|
IDA |
|
RGD |
PMID:2292503 |
RGD:7175546 |
NCBI chr 3:6,537,645...10,778,823
|
|
Q |
Ept18 |
Estrogen-induced pituitary tumorigenesis QTL 18 |
|
IDA |
|
RGD |
PMID:2292503 |
RGD:7175546 |
NCBI chr10:73,453,136...96,120,911
|
|
Q |
Ept5 |
Estrogen-induced pituitary tumorigenesis QTL 5 |
|
IDA |
27.5mg/ml crystalline implant |
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 4:83,428,419...177,635,233
|
|
Q |
Ept7 |
Estrogen-induced pituitary tumorigenesis QTL 7 |
|
IDA |
27.5mg/ml crystalline implant |
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 7:62,004,452...101,773,158
|
|
Q |
Eutr1 |
Estrogen induced uterine response QTL 1 |
|
IDA |
|
RGD |
PMID:16284801 |
RGD:1559292 |
NCBI chr 5:2,138,965...166,875,058
|
|
|
Q |
Edpm1 |
Estrogen-dependent pituitary mass QTL 1 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 2:35,134,841...88,029,593
|
|
Q |
Edpm10 |
Estrogen-dependent pituitary mass QTL 10 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
|
|
Q |
Edpm11 |
Estrogen-dependent pituitary mass QTL 11 |
|
IDA |
|
RGD |
PMID:11003699 |
RGD:629550 |
NCBI chr 9:1...43,718,459
|
|
Q |
Edpm12 |
Estrogen-dependent pituitary mass QTL 12 |
|
IDA |
|
RGD |
PMID:11003699 |
RGD:629550 |
NCBI chr X:2,927,898...47,927,898
|
|
Q |
Edpm2 |
Estrogen-dependent pituitary mass QTL 2 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 2:76,539,322...202,447,032
|
|
Q |
Edpm3 |
Estrogen-dependent pituitary mass QTL 3 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 3:53,184,692...89,878,207
|
|
Q |
Edpm5 |
Estrogen-dependent pituitary mass QTL 5 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 5:68,984,307...104,251,008
|
|
Q |
Edpm9 |
Estrogen-dependent pituitary mass QTL 9 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 9:63,869,687...108,869,687
|
|
Q |
Ept1 |
Estrogen-induced pituitary tumorigenesis QTL 1 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 6:9,843,312...20,338,915
|
|
Q |
Ept10 |
Estrogen-induced pituitary tumorigenesis QTL 10 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 1:192,825,253...243,914,732
|
|
Q |
Ept13 |
Estrogen-induced pituitary tumorigenesis QTL 13 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 1:77,494,165...122,494,165
|
|
Q |
Ept2 |
Estrogen-induced pituitary tumorigenesis QTL 2 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:47,233,430...110,362,260
|
|
Q |
Ept6 |
Estrogen-induced pituitary tumorigenesis QTL 6 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:6,537,645...10,778,823
|
|
Q |
Ept9 |
Estrogen-induced pituitary tumorigenesis QTL 9 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr10:73,453,136...96,120,911
|
|
Q |
Esta1 |
Estrogen-induced thymic atrophy QTL 1 |
|
IDA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr10:21,329,805...61,345,413
|
|
Q |
Esta2 |
Estrogen-induced thymic atrophy QTL 2 |
|
IDA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr 2:189,599,258...226,936,289
|
|
Q |
Esta3 |
Estrogen-induced thymic atrophy QTL 3 |
|
IDA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr 2:136,916,935...189,599,348
|
|
Q |
Esta4 |
Estrogen-induced thymic atrophy QTL 4 |
|
IDA |
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 3:47,233,211...147,415,807
|
|
Q |
Eutr2 |
Estrogen induced uterine response QTL 2 |
|
IDA |
|
RGD |
PMID:16284802 |
RGD:1559291 |
NCBI chr 5:34,730,116...104,251,008
|
|
Q |
Teswt1 |
Testicular weight QTL 1 |
|
IDA |
|
RGD |
PMID:16651691 |
RGD:1625009 |
NCBI chr 7:80,221,299...94,811,326
|
|
Q |
Teswt2 |
Testicular weight QTL 2 |
|
IDA |
|
RGD |
PMID:16651691 |
RGD:1625009 |
NCBI chr 1:197,697,768...238,755,659
|
|